- Home
- HCI vs RXRX Comparison
HCI vs RXRX Comparison
Compare HCI & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCI
- RXRX
- Stock Information
- Founded
- HCI 2006
- RXRX 2013
- Country
- HCI United States
- RXRX United States
- Employees
- HCI N/A
- RXRX N/A
- Industry
- HCI Property-Casualty Insurers
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- HCI Finance
- RXRX Health Care
- Exchange
- HCI Nasdaq
- RXRX Nasdaq
- Market Cap
- HCI 2.6B
- RXRX 2.2B
- IPO Year
- HCI N/A
- RXRX 2021
- Fundamental
- Price
- HCI $175.34
- RXRX $4.20
- Analyst Decision
- HCI Strong Buy
- RXRX Buy
- Analyst Count
- HCI 5
- RXRX 4
- Target Price
- HCI $230.00
- RXRX $7.25
- AVG Volume (30 Days)
- HCI 178.6K
- RXRX 37.9M
- Earning Date
- HCI 11-06-2025
- RXRX 11-05-2025
- Dividend Yield
- HCI 0.92%
- RXRX N/A
- EPS Growth
- HCI 32.29
- RXRX N/A
- EPS
- HCI 15.80
- RXRX N/A
- Revenue
- HCI $816,578,000.00
- RXRX $43,689,000.00
- Revenue This Year
- HCI $19.75
- RXRX $24.17
- Revenue Next Year
- HCI $8.24
- RXRX $20.96
- P/E Ratio
- HCI $11.03
- RXRX N/A
- Revenue Growth
- HCI 8.75
- RXRX N/A
- 52 Week Low
- HCI $106.03
- RXRX $3.79
- 52 Week High
- HCI $210.50
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- HCI 36.06
- RXRX 34.71
- Support Level
- HCI $176.10
- RXRX $4.46
- Resistance Level
- HCI $192.39
- RXRX $4.80
- Average True Range (ATR)
- HCI 8.05
- RXRX 0.33
- MACD
- HCI -3.40
- RXRX -0.13
- Stochastic Oscillator
- HCI 16.25
- RXRX 11.97
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are insurance operations, TypTap Group, reciprocal exchange operations, real estate operations, and corporate and other. It derives key revenue from the HCPCI Insurance operation segment.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.